Copyright
©The Author(s) 2025.
World J Diabetes. Aug 15, 2025; 16(8): 106215
Published online Aug 15, 2025. doi: 10.4239/wjd.v16.i8.106215
Published online Aug 15, 2025. doi: 10.4239/wjd.v16.i8.106215
Table 4 Follow up measurements of atherosclerotic variables and outcomes
| Variables | Intervention group (APRG) | Control group (SC) | P value |
| Pain score | 4.32 ± 0.98 | 4.64 ± 0.41 | 0.009 |
| ABI | 0.83 ± 0.66 | 0.73 ± 0.64 | 0.325 |
| Walking distance (m) | 321.49 ± 55.04 | 301.25 ± 43.95 | 0.013 |
| Claudication severity | 1.60 ± 1.58 | 2.12 ± 1.63 | 0.049 |
| Wound healing rate (%) | 82.78 ± 112.02 | 57.10 ± 18.23 | 0.046 |
| Flow value (mL/minute) | 29.28 ± 3.91 | 26.97 ± 6.20 | 0.008 |
| Patient satisfaction with treatment | 8.5 ± 1.9 | 7.1 ± 1.20 | 0.045 |
- Citation: Chen M, Li JT, Gao JB, Zhang L, Gao QH, Zeng X, Liu Q. Autologous platelet rich gel in treatment of lower limb atherosclerotic occlusive disease in diabetic patients. World J Diabetes 2025; 16(8): 106215
- URL: https://www.wjgnet.com/1948-9358/full/v16/i8/106215.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i8.106215